2019
DOI: 10.37358/rc.19.9.7510
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Data on Transitory Teriparatide-related Hypercalcemia in Daily Practice Treatment for Severe Menopausal Osteoporosis

Abstract: Teriparatide (TPT) (C181H291N55O51S2) represents a recombinant molecule acting as human osteoanabolic agent. Transitory hypercalcemia (TH) has been reported in osteoporotic patients treated with daily TPT. Our purpose is to analyze the biochemical features as well as clinical risk factors for fractures in patients with severe osteoporosis treated with TPT who developed TH during first 12 months. This is an observational real-life study. In patients with TH biochemical blood markers like osteocalcin, CrossLaps … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…Currently, there is specific treatment for this form of periodontitis associated with OP (37). However, treatment for OP may alter biochemical markers such as osteocalcin (38).…”
Section: Discussionmentioning
confidence: 99%
“…Currently, there is specific treatment for this form of periodontitis associated with OP (37). However, treatment for OP may alter biochemical markers such as osteocalcin (38).…”
Section: Discussionmentioning
confidence: 99%